查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1866357

全球下腔靜脈濾器市場－2025-2030年預測

Global Vena Cava Filters Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計下腔靜脈過濾器市場將從 2025 年的 11.74 億美元成長到 2030 年的 15.42 億美元，複合年成長率為 5.61%。

由於心血管疾病發病率上升、人口老化以及對微創手術需求的成長，全球下腔靜脈濾器市場預計將迎來顯著成長。下腔靜脈濾器置於上腔靜脈或下腔靜脈內，透過捕捉血栓來預防肺動脈栓塞，特別適用於無法接受抗凝血治療的患者。這些濾網分為永久型，滿足了深層靜脈栓塞症（DVT）治療的關鍵需求。儘管市場成長潛力巨大，但高昂的治療費用仍然是一大障礙，尤其是在發展中地區。

市場促進因素

心血管疾病激增與微創手術

根據世界衛生組織（世衛組織）的數據，心血管疾病是全球首要死因，每年約奪去1,790萬人的生命。如此高的發生率，加上人們越來越傾向於微創手術，推動了對下腔靜脈濾器的需求。這些裝置對於深層靜脈栓塞症（DVT）患者至關重要，而DVT約佔肺動脈栓塞的90%。醫學影像技術的進步，例如數位化導管實驗室，正在提高手術的精準度，並促進其進一步普及。預計到2030年，患者對這些技術的認知度不斷提高將推動需求成長，並支持市場發展。

人口老化加劇

根據聯合國估計，到2050年，全球老年人口預計將加倍，達到15億，這將是市場擴張的主要驅動力。老年人更容易患心血管疾病和深層靜脈栓塞症（DVT），這增加了對用於預防肺動脈栓塞的下腔靜脈濾器的需求。這種人口結構變化，加上久坐等生活方式相關因素，正在增加血管疾病的發生率，並促進這些設備在臨床應用中的普及。

優惠的報銷政策

已開發國家和開發中國家的支持性醫療保險報銷政策正在提高下腔靜脈濾器的可近性。這些政策減輕了患者的經濟負擔，促進了濾網的普及，並推動了市場成長。此外，濾網設計和植入系統的技術進步提高了其療效和安全性，進一步刺激了市場需求。

市場區隔與區域展望

依濾網類型分類，可回收濾網佔據主導地位，這類濾器柔韌性好，可在治療後取出。以介入方式分類，下腔靜脈濾器因其在治療下肢深層靜脈栓塞症（DVT）中的重要作用而佔據較大市場佔有率。按地區分類，北美和亞太地區預計將主導市場，這主要得益於心血管疾病的高發生率和人口老化。歐洲市場預計將因下腔靜脈濾器的日益普及而成長。

市場限制

高昂的手術費用仍然是一大挑戰，尤其是在開發中國家，這可能會限制手術的可及性並阻礙市場成長。這種經濟障礙可能會使患者不願意選擇下腔靜脈濾器植入術，影響整體需求。

競爭格局

ALN International, Inc.、Argon Medical Devices、B. Braun Medical, Inc.、Contego Medical, Inc.、Medtronic, Inc.、Johnson & Johnson、Boston Scientific Corporation、Cook Medical、Cordis 主要企業、Bard Peripheral Vascular, Inc. 和 Straub Medical AG 等領先企業正透過產品發布和戰略聯盟推動創新。這些努力旨在提高設備的精度和可靠性，以保持競爭優勢。

市場展望

受心血管疾病發病率上升、人口老化和技術進步的推動，下腔靜脈濾器市場預計到2030年將保持強勁成長。北美和亞太地區主導，歐洲的普及速度也正在加速。相關人員需要透過創新且經濟高效的解決方案來消除成本障礙，從而最大限度地發揮市場潛力並確保更廣泛的應用。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

5. 全球下腔靜脈濾器市場（按類型分類）

  • 介紹
  • 上腔靜脈濾器
  • 下腔靜脈濾器

6. 全球下腔靜脈濾網市場（依產品類型分類）

  • 介紹
  • 永久型過濾器
  • 可回收過濾器

7. 全球下腔靜脈濾器市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 門診手術中心
  • 其他

8. 全球下腔靜脈濾網市場（依地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 台灣
    • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Argon Medical Devices
  • B. Braun
  • Boston Scientific Corporation
  • Cook Medical
  • Cordis Corporation
  • Becton Dickinson
  • ALN Implants Chirurgicaux
  • Mermaid Medical A/S
  • Lifetech Scientific Corporation
  • Integer Holdings Corporation

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061611202

The Vena Cava Filters Market is anticipated to expand from USD 1.174 billion in 2025 to USD 1.542 billion in 2030, with a 5.61% CAGR.

The global vena cava filters market is set for significant growth, driven by the rising prevalence of cardiovascular diseases, an aging population, and increasing demand for minimally invasive procedures. Vena cava filters, deployed via the superior or inferior vena cava, prevent pulmonary embolism by capturing blood clots, particularly for patients unable to use anticoagulation therapies. Available as permanent or retrievable, these filters address critical needs in managing deep venous thrombosis (DVT). Despite growth prospects, high treatment costs pose a barrier, particularly in developing regions.

Market Drivers

Surge in Cardiovascular Diseases and Minimally Invasive Surgeries

Cardiovascular diseases, the leading global cause of death, claim approximately 17.9 million lives annually, according to the World Health Organization. This high prevalence, coupled with a growing preference for minimally invasive interventions, drives demand for vena cava filters. These devices are critical for patients with DVT, which accounts for about 90% of pulmonary embolisms. Advancements in medical imaging, such as digital catheterization laboratories, enhance procedural precision, further boosting adoption. Increasing patient awareness of these techniques is expected to amplify demand, supporting market growth through 2030.

Growing Geriatric Population

The global geriatric population, projected by the United Nations to double to 1.5 billion by 2050, significantly fuels market expansion. Older individuals are more susceptible to cardiovascular conditions and DVT, increasing the need for vena cava filters to prevent pulmonary embolism. This demographic shift, combined with lifestyle-related conditions like sedentary behavior, heightens the incidence of vascular issues, driving the adoption of these devices in clinical settings.

Favorable Reimbursement Policies

Supportive reimbursement frameworks in developed and developing countries are enhancing the accessibility of vena cava filters. These policies reduce financial burdens for patients, encouraging adoption and contributing to market growth. Additionally, technological advancements in filter design and deployment systems are improving efficacy and safety, further propelling market demand.

Market Segments and Geographical Outlook

By filter type, retrievable filters dominate due to their flexibility, allowing removal post-treatment. By intervention type, inferior vena cava filters hold a significant share, driven by their critical role in addressing lower limb DVTs. Geographically, North America and Asia-Pacific regions are expected to lead, fueled by high cardiovascular disease prevalence and aging populations. Europe's market share is projected to grow due to increasing adoption of inferior vena cava filters.

Market Restraints

High procedure costs remain a significant challenge, particularly in developing countries, limiting accessibility and potentially constraining market growth. This affordability barrier may deter patients from opting for vena cava filter treatments, impacting overall demand.

Competitive Landscape

Key players, including ALN International, Inc., Argon Medical Devices, B. Braun Medical, Inc., Contego Medical, Inc., Medtronic, Inc., Johnson & Johnson, Boston Scientific Corporation, Cook Medical, Cordis Corporation, Bard Peripheral Vascular, Inc., and Straub Medical AG, drive innovation through product launches and strategic partnerships. These efforts focus on enhancing device precision and reliability to maintain competitive edges.

Market Outlook

The vena cava filters market is poised for robust growth through 2030, driven by rising cardiovascular disease incidence, an aging population, and technological advancements. While North America and Asia-Pacific lead, Europe's adoption is accelerating. Stakeholders must address cost barriers through innovative, cost-effective solutions to maximize market potential and ensure broader accessibility.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Type

  • Superior Vena Cava Filters
  • Inferior Vena Cava Filters

By Product Type

  • Permanent Filter
  • Retrievable Filter

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL VENA CAVA FILTERS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Superior Vena Cava Filters
  • 5.3. Inferior Vena Cava Filters

6. GLOBAL VENA CAVA FILTERS MARKET BY PRODUCT TYPE

  • 6.1. Introduction
  • 6.2. Permanent Filter
  • 6.3. Retrievable Filter

7. GLOBAL VENA CAVA FILTERS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Others

8. GLOBAL VENA CAVA FILTERS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Taiwan
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Argon Medical Devices
  • 10.2. B. Braun
  • 10.3. Boston Scientific Corporation
  • 10.4. Cook Medical
  • 10.5. Cordis Corporation
  • 10.6. Becton Dickinson
  • 10.7. ALN Implants Chirurgicaux
  • 10.8. Mermaid Medical A/S
  • 10.9. Lifetech Scientific Corporation
  • 10.10. Integer Holdings Corporation

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations